These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 2351168)
1. Regional rates of myocardial fatty acid metabolism: comparison with coronary angiography and ventriculography. Schad N; Wagner RK; Hallermeier J; Daus HJ; Vattimo A; Bertelli P Eur J Nucl Med; 1990; 16(4-6):205-12. PubMed ID: 2351168 [TBL] [Abstract][Full Text] [Related]
2. Iodine-123 phenylpentadecanoic acid and single photon emission computed tomography in identifying left ventricular regional metabolic abnormalities in patients with coronary heart disease: comparison with thallium-201 myocardial tomography. Hansen CL; Corbett JR; Pippin JJ; Jansen DE; Kulkarni PV; Ugolini V; Henderson E; Akers M; Buja LM; Parkey RW J Am Coll Cardiol; 1988 Jul; 12(1):78-87. PubMed ID: 3259960 [TBL] [Abstract][Full Text] [Related]
3. [Reduced myocardial fatty acid utilization in coronary heart disease following symptom limited ergometric stress. Detection of pathologic metabolic patterns using iodine-123-phenylpentadecanoic acid and sequential SPECT]. Reske SN; Nitsch J; von der Lohe E; Simon HJ; Bardos P; Büll U Z Kardiol; 1989 Apr; 78(4):262-70. PubMed ID: 2786661 [TBL] [Abstract][Full Text] [Related]
4. Metabolic cardiac imaging in severe coronary disease: assessment of viability with iodine-123-iodophenylpentadecanoic acid and multicrystal gamma camera, and correlation with biopsy. Murray G; Schad N; Ladd W; Allie D; vander Zwagg R; Avet P; Rockett J J Nucl Med; 1992 Jul; 33(7):1269-77. PubMed ID: 1613564 [TBL] [Abstract][Full Text] [Related]
5. Preliminary report of an ongoing phase I/II dose range, safety and efficacy study of iodine-123-phenylpentadecanoic acid for the identification of viable myocardium. Hansen CL J Nucl Med; 1994 Apr; 35(4 Suppl):38S-42S. PubMed ID: 8151411 [TBL] [Abstract][Full Text] [Related]
6. Prediction of improvement in left ventricular function with iodine-123-IPPA after coronary revascularization. Hansen CL; Heo J; Oliner C; Van Decker W; Iskandrian AS J Nucl Med; 1995 Nov; 36(11):1987-93. PubMed ID: 7472586 [TBL] [Abstract][Full Text] [Related]
8. Myocardial scintigraphy with iodine-123 phenylpentadecanoic acid and thallium-201 in patients with coronary artery disease: a comparative dual-isotope study. Zimmermann R; Rauch B; Kapp M; Bubeck B; Neumann FJ; Seitz F; Stokstad P; Mall G; Tillmanns H; Kübler W Eur J Nucl Med; 1992; 19(11):946-54. PubMed ID: 1425781 [TBL] [Abstract][Full Text] [Related]
9. Viability after myocardial infarction: can it be assessed within five minutes by low-dose dynamic iodine-123-iodophenylpentadecanoic acid imaging with a multicrystal gamma camera? Murray GL; Schad N; Bush AJ Angiology; 1997 Apr; 48(4):309-19. PubMed ID: 9112879 [TBL] [Abstract][Full Text] [Related]
10. [Myocardial scintigraphy with iodine 123-labeled fatty acids]. Dudczak R Wien Klin Wochenschr Suppl; 1983; 143():3-35. PubMed ID: 6228070 [TBL] [Abstract][Full Text] [Related]
11. 123I-IPPA SPECT for the prediction of enhanced left ventricular function after coronary bypass graft surgery. Multicenter IPPA Viability Trial Investigators. 123I-iodophenylpentadecanoic acid. Verani MS; Taillefer R; Iskandrian AE; Mahmarian JJ; He ZX; Orlandi C J Nucl Med; 2000 Aug; 41(8):1299-307. PubMed ID: 10945518 [TBL] [Abstract][Full Text] [Related]